Efficacy of Boswellia serrata L. and Cyperus scariosus L. plus pelvic floor muscle training in stress incontinence in women of reproductive age

Tsai, 2009, Urinary incontinence among Taiwanese women: an outpatient study of prevalence, comorbidity,risk factors, and quality of life, Int Urol Nephrol, 41, 795, 10.1007/s11255-009-9523-3

Kim, 2007, A safety and quality of life analysis of intravaginal slingplasty in female stress incontinence: a prospective, open label, multicenter, and observational study, Int Urogynecol J, 18, 1331, 10.1007/s00192-007-0327-7

Athanasopoulos, 2009, Pharmacotherapy of urinary incontinence, Int Urogynecol J Pelvic Floor Dysfunct, 20, 475, 10.1007/s00192-008-0761-1

Shahali, 2010, Effects of pelvic floor muscle exercises on quality of life outcomes inwomen with stress urinary incontinence, Med J Islamic Repub Iran, 24, 159

Bakar, 2011, The use of extracorporeal magnetic innervation for the treatmentof stress urinary incontinence in older women: a pilot study, Arch Gynecol Obstet, 284, 1163, 10.1007/s00404-010-1814-5

Hong, 2009, Long-term results of laparoscopic burch colposuspension for stress urinary incontinence in women, Korean Med Sci, 24, 1182, 10.3346/jkms.2009.24.6.1182

Kerr, 2005, Bulking agents in the treatment of stress urinary incontinence: history, outcomes, patient populations, and reimbursement profile, Rev Urol, 7, S3

Tannenbaum, 2008, rating improvements in urinary incontinence: do patients and their physicians agree?, Age Ageing, 37, 379, 10.1093/ageing/afn108

ter Meulen, 2009, Effects of Macroplastique® implantation system for stressurinary incontinence and urethral hypermobility in women, Int Urogynecol J Pelvic Floor Dysfunct, 20, 177, 10.1007/s00192-008-0741-5

Nygaard, 2004, Stress urinary incontinence, Obstet Gynecol, 104, 607, 10.1097/01.AOG.0000137874.84862.94

Ghoniem, 2005, A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence, J Urol, 173, 1647

Ghani, 2001

Bhagwat, 2009, Cyperusscariosus chloroform fraction inhibits t cell responses in Balb/C mice, Tropical J Pharm Res, 8, 399, 10.4314/tjpr.v8i5.48083

Singh, 1986, Pharmacology of an extract of salaiguggal ex-Boswelliaserrata, a new nonsteroidal anti-inflammatory agent, Agents Actions, 18, 407, 10.1007/BF01965005

Kafri, 2007, Rehabilitation vs drug therapy for urge urinary incontinence: short-term outcome, Int Urogynecol J, 18, 407, 10.1007/s00192-006-0163-1

Karantanis, 2004, Comparison of the ICIQ-SF and 24-hour pad test with other measures for evaluating the severity of urodynamic stress incontinence, Int Urogynecol J Pelvic Floor Dysfunct, 15, 111, 10.1007/s00192-004-1123-2

Samuelsson, 1999, Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors, Am J Obstet Gynecol, 180, 299, 10.1016/S0002-9378(99)70203-6

Persu, 2011, Pelvic organ prolapse quantification system (POP–Q) – a new era in pelvic prolapse staging, J Med Life, 4, 75

Beiber, 2006, 377

Versi, 1988, The use of pad tests in the investigation of female urinary incontinence, J Obstet Gynaecol, 8, 270, 10.3109/01443618809012303

Lose, 1992, Pad-weighing tests in the diagnosis and quantification of incontinence, Int Urogyneeol J, 3, 324, 10.1007/BF00499653

Tchou, 1988, Pelvic-floor musculature exercises in treatment of anatomical urinary stress incontinence, Phys Ther, 68, 652, 10.1093/ptj/68.5.652

Price, 2010, Pelvic floor exercise for urinary incontinence: a systematic literature review, Maturitas, 67, 309, 10.1016/j.maturitas.2010.08.004

Castro-Diaz, 2007, Effect of dose escalation on the tolerability and efficacy of duloxetine in the treatment of women with stress urinary incontinence, Int Urogynecol J, 18, 919, 10.1007/s00192-006-0256-x

Moussaieff, 2009, Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials, JPP, 61, 1281, 10.1211/jpp.61.10.0003

Anonymous, 1988, vol. 2, 203

Moussaieff, 2008, Incensole acetate, an incense component, elicits psychoactivity by activating TRPV3 channels in the brain, FASEB J, 22, 3024, 10.1096/fj.07-101865

Upaganlawar, 2009, Pharmacological activities of Boswellia serrate Roxb – mini review, Ethnobot Leafl, 13, 766

Anonymous, 2001, vol. 2, 334

Ross, 2003, vol. 1, 209

Basu, 2009, Update on duloxetine for the management of stress urinary incontinence, Clin Interv Aging, 4, 25

Deepak, 2011, Duloxetine- pharmacological aspects, Int J Biol Med Res, 2, 589

Felde, 2012, Anxiety and depression associated with incontinencein middle-aged women: a large Norwegiancross-sectional study, Int Urogynecol J, 23, 299, 10.1007/s00192-011-1564-3

Ramesh, 2012, Pharmacological study of anti-depressant like activity of Cyperusscariosusoil in mice, Int Res J Pharm App Sci, 2, 139

Berghmans, 2000, Conservative treatment of urge urinary incontinence in women: a systematic review of randomized clinical trials, BJU Int, 85, 254, 10.1046/j.1464-410x.2000.00434.x